FLUMEQUINE 50%/NEOCELL ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
FLUMEQUINE 50%/NEOCELL ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
Authorised
- Flumequine
Product identification
Medicine name:
FLUMEQUINE 50%/NEOCELL ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
- Flumequine
Target species:
-
Chicken (hen)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Flumequine500.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Powder for oral solution
Withdrawal period by route of administration:
-
Oral use
-
Chicken (hen)
-
Meat and offal3dayνα μη χορηγείται σε αυγοπαραγωγές όρνιθες τα αυγά των οποίων προορίζονται για ανθρώπινη κατανάλωση
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MB07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Neocell Ltd.
Marketing authorisation date:
Manufacturing sites for batch release:
- Uplab Pharmaceutical Company Ltd.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 64933/29-05-2019/K-0208701
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
